Under construction – not a live service
Sign in

550 open Type 1 diabetes trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.

CountryOpen trials
United States216
Canada51
France43
China40
Denmark35
All other countries

The same trial often runs in several countries

Long-Term Outcomes of Teplizumab in Routine Clinical Care has 2 sites in United Arab Emirates and runs in 4 countries. If a site near you is full, another one may still take people.

See Long-Term Outcomes of Teplizumab in Routine Clinical Care in all 4 countries
Under construction, not live – Type 1 diabetes trials in United Arab Emirates – Frontlight Research